CompletedN/ANCT05982821

A Multicenter Study of Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Trial Details

ConditionThyroid Nodule
InterventionArtificial Intelligence
PhaseN/A
StatusCompleted
Participants1,955
Est. Completion2 Mar 2026
Last Updated25 Mar 2026

Primary Outcome

Diagnostic performance; The necessity of biopsy

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patients with thyroid nodules with a solid component ≥5 mm confirmed by conventional ultrasound; * Patients who underwent conventional ultrasound, contrast-enhanced ultrasound, and fine-needle aspiration biopsy; * Patients with a final benign or malignant pathological results. Exclusion Criteria: * Patients with cytopathology of Bethesda I, III, or IV and without final benign or malignant pathology; * Patients with a history of thyroid ablation or surgery; * Patients with low-quality ultrasound images.

Trial Sites

Countries

China
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service